Sloves Andrew
Known title: DirectorCIK: 0001679934
Associated companies
Transaction History
| RITM | ▲ Buy | Grant | 14,066 | $0 | 5/24/2024 | View on chart |
| RITM | ▲ Buy | Grant | 12,178 | $0 | 12/29/2023 | View on chart |
| RITM | ▲ Buy | Grant | 18,972 | $0 | 5/26/2023 | View on chart |
| RITM | ▲ Buy | Grant | 15,300 | $0 | 1/4/2023 | View on chart |
| RITM | ▲ Buy | Grant | 8,048 | $0 | 6/30/2022 | View on chart |
| RITM | ▲ Buy | Grant | 8,874 | $0 | 5/27/2022 | View on chart |
| RITM | ▲ Buy | Grant | 9,116 | $0 | 1/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Rithm Capital Forms Joint Venture for Midtown Office Tower
Rithm Capital and DRA Advisors announced a joint venture to own the 1301 Avenue of the Americas office tower. DRA Advisors holds a 49% stake in the $1.3 billion property. This deal expands Rithm's commercial real estate portfolio. The stock is currently trading near its 52-week low, with an RSI indicating oversold conditions.
Rithm Capital Forms Joint Venture for Midtown Office Tower. Rithm Capital and DRA Advisors announced a joint venture to own the 1301 Avenue of the Americas office tower. DRA Advisors holds a 49% stake in the $1.3 billion property. This deal expands Rithm's commercial real estate portfolio. The stock is currently trading near its 52-week low, with an RSI indicating oversold conditions.